| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -5.6e-05 | 1 |